Combination treatment with a GLP-1 agonist and thiazolidinedione in type 2 diabetes was tied to a significantly lower risk of ...

Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, diabetes experts warn.

Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, UVA Health diabetes experts note in a new paper highlighting a growing ...

Embecta Corp. (NASDAQ: EMBC) was unchanged Tuesday, as the global diabetes care company with a 100-year legacy in insulin delivery announced a new landmark publication in the Mayo Clinic Proceedings.

First Update in Nearly 10 Years by FITTER Forward Initiative Sets Out to Transform Insulin Injection Technique EducationPARSIPPANY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") ...

A series of sleep studies confirmed that Guber had severe obstructive sleep apnea and was ceasing to breathe for several seconds, as often as 30 times each hour. With each episode, he was awakened by ...

Full REMAIN-1 pivotal study enrollment anticipated in summer 2025 ...

An alleged prototype of the Apple Watch Series 10 has a brand new sensor that may have been intended for blood sugar ...

Ultra-processed foods, or UPFs for short, are suddenly the hot health concept — the new antihero in global diets. The topic ...

Researchers are refining the state-of-the-art tech to calculate calorie count, fat content, and nutritional value from images ...

An advanced hybrid closed-loop insulin delivery system is safe to use for pregnant women with type 1 diabetes and may provide ...